These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 7908970)

  • 21. Postprandial normal saline intake delays gastric emptying of solids in conscious dogs: partial involvement of CCK in its mechanism.
    Tanaka T; Mizumoto A; Muramatsu S; Mochiki E; Haga N; Suzuki H; Itoh Z
    Dig Dis Sci; 1999 Aug; 44(8):1516-24. PubMed ID: 10492127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of cholecystokinin receptor in the inhibition of gastric emptying by oxytocin in male rats.
    Wu CL; Hung CR; Chang FY; Pau KY; Wang JL; Wang PS
    Pflugers Arch; 2002 Nov; 445(2):187-93. PubMed ID: 12457239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.
    Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Coker LD; Turnbull TA; Morita ET
    J Clin Invest; 1989 Oct; 84(4):1220-5. PubMed ID: 2794058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A possible interaction between serotonin and cholecystokinin-8 in the ileo-colonic motor responses to feeding in rats.
    Benouali-Pellissier S; Roger T; Roche M
    Scand J Gastroenterol; 1994 Feb; 29(2):138-43. PubMed ID: 8171281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Action of the cholecystokinin antagonist L364,718 on gastric emptying in the rat.
    Green T; Dimaline R; Peikin S; Dockray GJ
    Am J Physiol; 1988 Nov; 255(5 Pt 1):G685-9. PubMed ID: 3056036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of cholecystokinin in the gastric motor response to a meal in horses.
    Lorenzo-Figueras M; Merritt AM
    Am J Vet Res; 2006 Dec; 67(12):1998-2005. PubMed ID: 17144800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Voluntary intake and gastric emptying in pigs: effects of fat and a CCK inhibitor.
    Rayner DV; Miller S
    Physiol Behav; 1993 Nov; 54(5):917-22. PubMed ID: 8248383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of the cholecystokinin receptor antagonist MK-329 on meal-stimulated pancreaticobiliary output in humans.
    Cantor P; Mortensen PE; Myhre J; Gjorup I; Worning H; Stahl E; Survill TT
    Gastroenterology; 1992 May; 102(5):1742-51. PubMed ID: 1568584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholecystokinin receptor antagonist MK-329 blocks intestinal fat-induced inhibition of meal-stimulated gastric acid secretion.
    Lloyd KC; Maxwell V; Kovacs TO; Miller J; Walsh JH
    Gastroenterology; 1992 Jan; 102(1):131-8. PubMed ID: 1727746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integration of postprandial function in the proximal gastrointestinal tract. Role of CCK and sensory pathways.
    Raybould HE; Lloyd KC
    Ann N Y Acad Sci; 1994 Mar; 713():143-56. PubMed ID: 8185155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
    Nylander AG; Chen D; Ihse I; Rehfeld JF; Håkanson R
    Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Devazepide alters meal patterns in lean, but not obese, male Zucker rats.
    Strohmayer AJ; Greenberg D
    Physiol Behav; 1994 Nov; 56(5):1037-9. PubMed ID: 7824568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ileal brake failure in streptozotocin-induced diabetic rat.
    Martín MT; Azpiroz F; Malagelada JR
    Scand J Gastroenterol; 2004 May; 39(5):423-7. PubMed ID: 15180178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral biological activity of SR 27897: a new potent non-peptide antagonist of CCKA receptors.
    Gully D; Fréhel D; Marcy C; Spinazzé A; Lespy L; Neliat G; Maffrand JP; Le Fur G
    Eur J Pharmacol; 1993 Feb; 232(1):13-9. PubMed ID: 7681406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastrointestinal effects of diazepam-withdrawal are linked to activation of central cholecystokinin-ergic pathways in rats.
    Bonnafous C; Martinez J; Bueno L
    J Pharm Pharmacol; 1994 Oct; 46(10):784-8. PubMed ID: 7699563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal transit of fat depends on accelerating effect of cholecystokinin and slowing effect of an opioid pathway.
    Lin HC; Zaidel O; Hum S
    Dig Dis Sci; 2002 Oct; 47(10):2217-21. PubMed ID: 12395894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A model of gastric emptying in cats shows solid emptying is promoted by MK-329: a CCK antagonist.
    Gould RJ; Fioravanti C; Cook PG; Solomon HF
    J Nucl Med; 1990 Sep; 31(9):1494-9. PubMed ID: 2203881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous cholecystokinin reduces feeding in young rats.
    Weller A; Smith GP; Gibbs J
    Science; 1990 Mar; 247(4950):1589-91. PubMed ID: 2321020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of endogenous cholecystokinin in biliary, pancreatic and gastric function: studies with L-364,718, a specific cholecystokinin receptor antagonist.
    Pendleton RG; Bendesky RJ; Schaffer L; Nolan TE; Gould RJ; Clineschmidt BV
    J Pharmacol Exp Ther; 1987 Apr; 241(1):110-6. PubMed ID: 2437283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous infusion of CCKA-receptor antagonist increases food intake in rats.
    Miesner J; Smith GP; Gibbs J; Tyrka A
    Am J Physiol; 1992 Feb; 262(2 Pt 2):R216-9. PubMed ID: 1539728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.